FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Draft Guide on Cell/Gene Therapy Considerations

Federal Register notice: FDA makes available a draft document entitled Considerations for the Use of Human- and Animal-Derived Materials and Component...

latest-news-card-1
Federal Register

Guide on Composition and Ingredient Statements

Federal Register notice: FDA makes available a draft guidance entitled Content and Format of Composition Statements in NDAs and ANDAs and Correspondin...

latest-news-card-1
FDA General

Listening Session on Improving Advisory Committees

FDA plans a 6/13 listening session as part of its plan to revamp the use of advisory committees.

latest-news-card-1
Medical Devices

4-Year Enforcement Discretion for LDTs: Final Rule

FDA offers a four-year enforcement discretion phase-out under a just-released final rule regulating laboratory-developed tests.

latest-news-card-1
Biologics

Human/Animal Materials in Cell/Gene Therapies Guide

FDA posts a draft guidance entitled Considerations for the Use of Human- and Animal-Derived Materials in the Manufacture of Cell and Gene Therapy and ...

latest-news-card-1
Medical Devices

SonarMed Recalls Airway Sensors

SonarMed recalls its SonarMed Airway acoustic ventilator sensors due to a restricted inner diameter of the device resulting in difficulty passing a su...

latest-news-card-1
Federal Register

Panel to Review Novo Nordisks Insulin Icodec

Federal Register notice: FDA schedules a 5/24 Advisory Committee meeting to discuss Novo Nordisks BLA for insulin icodec.

latest-news-card-1
Biologics

Human Allogeneic Cell Safety Testing Guide

FDA posts a draft guidance entitled Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products.

latest-news-card-1
Human Drugs

X4 Pharma Gains Xolremdi Approval

FDA approves an X4 Pharmaceuticals NDA for Xolremdi (mavorixafor) and its use in patients 12 years of age and older with WHIM syndrome (warts, hypogam...

latest-news-card-1
Federal Register

Clinical Pharmacology Office Priorities Docket

Federal Register notice: FDA creates a public docket entitled Promoting Effective Drug Development: Identifying Opportunities and Priorities for the F...